China Pharmacopoeia Commission: Pharmacopoeia of the People's Republic of China. 2020 edition, Part 1. Chinese medicines and Technology Press, Beijing, 2020.

Dai RC, Nabil WNN and Xu HX: The history of saffron in China: From its origin to applications. Chin Med Cult. 4:228–234. 2021.

Huang WJ and Long CL: The medicinal history and recent study of Crocus sativus. J Minzu Univ China (Natural Sciences Edition). 24:55–58. 2015.

Samarghandian S and Borji A: Anticarcinogenic effect of saffron (Crocus sativus L.) and its ingredients. Pharmacognosy Res. 6:99–107. 2014.PubMed/NCBI View Article : Google Scholar

Valle García-Rodríguez M, Serrano-Díaz J, Tarantilis PA, López-Córcoles H, Carmona M and Alonso GL: Determination of saffron quality by high-performance liquid chromatography. J Agric Food Chem. 62:8068–8074. 2014.PubMed/NCBI View Article : Google Scholar

Hatziagapiou K and Lambrou GI: The protective role of Crocus sativus L. (saffron) against ischemia-reperfusion injury, hyperlipidemia and atherosclerosis: Nature opposing cardiovascular diseases. Curr Cardiol Rev. 14:272–289. 2018.PubMed/NCBI View Article : Google Scholar

Thushara RM, Hemshekhar M, Santhosh MS, Jnaneshwari S, Nayaka SC, Naveen S, Kemparaju K and Girish KS: Crocin, a dietary additive protects platelets from oxidative stress-induced apoptosis and inhibits platelet aggregation. Mol Cell Biochem. 373:73–83. 2013.PubMed/NCBI View Article : Google Scholar

Rahmani J, Manzari N, Thompson J, Clark CCT, Villanueva G, Varkaneh HK and Mirmiran P: The effect of saffron on weight and lipid profile: A systematic review, meta-analysis, and dose-response of randomized clinical trials. Phytother Res. 33:2244–2255. 2019.PubMed/NCBI View Article : Google Scholar

Zhang A, Shen Y, Cen M, Hong X, Shao QS, Chen Y and Zheng B: Polysaccharide and crocin contents, and antioxidant activity of saffron from different origins. Ind Crop Prod. 133:111–117. 2019.

Xue Y, Jin W, Xue Y, Zhang Y, Wang H, Zhang Y, Guan S, Chu X and Zhang J: Safranal, an active constituent of saffron, ameliorates myocardial ischemia via reduction of oxidative stress and regulation of Ca²⁺ homeostasis. J Pharmacol Sci. 143:156–164. 2020.PubMed/NCBI View Article : Google Scholar

Poma A, Fontecchio G, Carlucci G and Chichiriccò G: Anti-inflammatory properties of drugs from saffron crocus. Antiinflamm Antiallergy Agents Med Chem. 11:37–51. 2012.PubMed/NCBI View Article : Google Scholar

Singh G, Haileselassie Y, Ji AR, Maecker HT, Sinha SR, Brim H, Habtezion A and Ashktorab H: Protective effect of saffron in mouse colitis models through immune modulation. Digest Dis Sci. 67:2922–2935. 2022.PubMed/NCBI View Article : Google Scholar

Lambrianidou A, Koutsougianni F, Papapostolou I and Dimas K: Recent advances on the anticancer properties of saffron (Crocus sativus L.) and its major constituents. Molecules. 26(86)2020.PubMed/NCBI View Article : Google Scholar

Siddiqui SA, Ali Redha A, Snoeck ER, Singh S, Simal-Gandara J, Ibrahim SA and Jafari SM: Anti-depressant properties of crocin molecules in saffron. Molecules. 27(2076)2022.PubMed/NCBI View Article : Google Scholar

José Bagur M, Alonso Salinas GL, Jiménez-Monreal AM, Chaouqi S, Llorens S, Martínez-Tomé M and Alonso GL: Saffron: An old medicinal plant and a potential novel functional food. Molecules. 23(30)2017.PubMed/NCBI View Article : Google Scholar

Howes MR, Perry NSL, Vásquez-Londoño C and Perry EK: Role of phytochemicals as nutraceuticals for cognitive functions affected in ageing. Br J Pharmacol. 177:1294–1315. 2020.PubMed/NCBI View Article : Google Scholar

Bathaie SZ: Saffron as a functional food and a nutraceutical using saffron and its constituents as the nutraceutics to protect against chronic diseases. Acta Hortic. 1200:201–204. 2018.

Hardy J: Pathways to primary neurodegenerative disease. Ann N Y Acad Sci. 924:29–34. 2000.PubMed/NCBI View Article : Google Scholar

Höglund K and Salter H: Molecular biomarkers of neurodegeneration. Expert Rev Mol Diagn. 13:845–861. 2013.PubMed/NCBI View Article : Google Scholar

Sheikh S, Safia Haque E and Mir SS: Neurodegenerative diseases: Multifactorial conformational diseases and their therapeutic interventions. J Neurodegener Dis. 2013(563481)2013.PubMed/NCBI View Article : Google Scholar

Di Stefano A, Sozio P and Cerasa LS: Antiparkinson prodrugs. Molecules. 13:46–68. 2008.PubMed/NCBI View Article : Google Scholar

Klietz M, Greten S, Wegner F and Höglinger GU: Safety and tolerability of pharmacotherapies for Parkinson's disease in geriatric patients. Drugs Aging. 36:511–530. 2019.PubMed/NCBI View Article : Google Scholar

Hosseinzadeh H and Sadeghnia HR: Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. J Pharm Pharm Sci. 8:394–399. 2005.PubMed/NCBI

Salem M, Shaheen M, Tabbara A and Borjac J: Saffron extract and crocin exert anti-inflammatory and anti-oxidative effects in a repetitive mild traumatic brain injury mouse model. Sci Rep. 12(5004)2022.PubMed/NCBI View Article : Google Scholar

Saeedi M and Rashidy-Pour A: Association between chronic stress and Alzheimer's disease: Therapeutic effects of Saffron. Biomed Pharmacother. 133(110995)2021.PubMed/NCBI View Article : Google Scholar

Gregory J, Vengalasetti YV, Bredesen DE and Rao RV: Neuroprotective herbs for the management of Alzheimer's disease. Biomolecules. 11(543)2021.PubMed/NCBI View Article : Google Scholar

Hatziagapiou K, Kakouri E, Lambrou GI, Bethanis K and Tarantilis PA: Antioxidant properties of Crocus Sativus L. and its constituents and relevance to neurodegenerative diseases; Focus on Alzheimer's and Parkinson's disease. Curr Neuropharmacol. 17:377–402. 2019.PubMed/NCBI View Article : Google Scholar

Ghasemi Sakha F, Azimi Saeen A, Moazzeni SM, Etesam F and Vaezi G: A randomized, triple-blind placebo-controlled trial to determine the effect of saffron on the serum levels of MMP-9 and TIMP-1 in patients with multiple sclerosis. Iran J Allergy Asthma Immunol. 19:297–304. 2020.PubMed/NCBI View Article : Google Scholar

Yuan Y, Shan X, Men W, Zhai H, Qiao X, Geng L and Li C: The effect of crocin on memory, hippocampal acetylcholine level, and apoptosis in a rat model of cerebral ischemia. Biomed Pharmacother. 130(110543)2020.PubMed/NCBI View Article : Google Scholar

Jahromi GP, Khodadadi H, Fasihi-Ramandi M, Esmaeili M and Shahriary A: Neuroprotective and antiapoptotic effects of N-acetylcystein and Crocus sativus aqueous extract on arsenic-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells. Indian J Pharm Educ Res. 53:695–702. 2019.

Razavi BM and Hosseinzadeh H: Saffron as an antidote or a protective agent against natural or chemical toxicities. Daru. 23(31)2015.PubMed/NCBI View Article : Google Scholar

Chuquilín-Arista F, Álvarez-Avellón T and Menéndez-González M: Prevalence of depression and anxiety in Parkinson disease and impact on quality of life: A community-based study in Spain. J Geriatr Psychiatry Neurol. 33:207–213. 2020.PubMed/NCBI View Article : Google Scholar

Farkhondeh T, Samarghandian S, Shaterzadeh Yazdi H and Samini F: The protective effects of crocin in the management of neurodegenerative diseases: A review. Am J Neurodegener Dis. 7:1–10. 2018.PubMed/NCBI

Bian Y, Zhao C and Lee SMY: Neuroprotective potency of saffron against neuropsychiatric diseases, neurodegenerative diseases, and other brain disorders: From bench to bedside. Front Pharmacol. 11(579052)2020.PubMed/NCBI View Article : Google Scholar

Uttara B, Singh AV, Zamboni P and Mahajan RT: Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 7:65–74. 2009.PubMed/NCBI View Article : Google Scholar

Halliwell B: Oxidative stress and neurodegeneration: Where are we now? J Neurochem. 97:1634–1658. 2006.PubMed/NCBI View Article : Google Scholar

Praticò D: Oxidative stress hypothesis in Alzheimer's disease: A reappraisal. Trends Pharmacol Sci. 29:609–615. 2008.PubMed/NCBI View Article : Google Scholar

Reynolds A, Laurie C, Mosley RL and Gendelman HE: Oxidative stress and the pathogenesis of neurodegenerative disorders. Int Rev Neurobiol. 82:297–325. 2007.PubMed/NCBI View Article : Google Scholar

Wojsiat J, Zoltowska KM, Laskowska-Kaszub K and Wojda U: Oxidant/antioxidant imbalance in Alzheimer's disease: Therapeutic and diagnostic prospects. Oxid Med Cell Longev. 2018(6435861)2018.PubMed/NCBI View Article : Google Scholar

Danielson SR and Andersen JK: Oxidative and nitrative protein modifications in Parkinson's disease. Free Radical Bio Med. 44:1787–1794. 2008.PubMed/NCBI View Article : Google Scholar

Yamamoto A, Shin RW, Hasegawa K, Naiki H, Sato H, Yoshimasu F and Kitamoto T: Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: Implications in the formation of neurofibrillary tangles of Alzheimer's disease. J Neurochem. 82:1137–1147. 2002.PubMed/NCBI View Article : Google Scholar

Su B, Wang X, Lee HG, Tabaton M, Perry G, Smith MA and Zhu X: Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells. Neurosci Lett. 468:267–271. 2010.PubMed/NCBI View Article : Google Scholar

Kumar V and Gill KD: Oxidative stress and mitochondrial dysfunction in aluminium neurotoxicity and its amelioration: A review. Neurotoxicology. 41:154–166. 2014.PubMed/NCBI View Article : Google Scholar

Lim J and Yue Z: Neuronal aggregates: Formation, clearance, and spreading. Dev Cell. 32:491–501. 2015.PubMed/NCBI View Article : Google Scholar

Sabayan B, Namazi MR, Mowla A and Moniri SA: Are patients with Darier and Haily-Haily diseases susceptible to Alzheimer's disease? A theory based on abnormal intraneuronal Ca2+ homeostasis. J Alzheimers Dis. 16:521–523. 2009.PubMed/NCBI View Article : Google Scholar

Singh N, Haldar S, Tripathi AK, McElwee MK, Horback K and Beserra A: Iron in neurodegenerative disorders of protein misfolding: A case of prion disorders and Parkinson's disease. Antioxid Redox Signal. 21:471–484. 2014.PubMed/NCBI View Article : Google Scholar

Hare DJ and Double KL: Iron and dopamine: A toxic couple. Brain. 139:1026–1035. 2016.PubMed/NCBI View Article : Google Scholar

Batarseh YS, Bharate SS, Kumar V, Kumar A, Vishwakarma RA, Bharate SB and Kaddoumi A: Crocus sativus extract tightens the blood-brain barrier, reduces Amyloid β load and related toxicity in 5XFAD mice. ACS Chem Neurosci. 8:1756–1766. 2017.PubMed/NCBI View Article : Google Scholar

Papandreou MA, Kanakis CD, Polissiou MG, Efthimiopoulos S, Cordopatis P, Margarity M and Lamari FN: Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. J Agric Food Chem. 54:8762–8768. 2006.PubMed/NCBI View Article : Google Scholar

Shati AA, Elsaid FG and Hafez EE: Biochemical and molecular aspects of aluminium chloride-induced neurotoxicity in mice and the protective role of Crocus sativus L. extraction and honey syrup. Neuroscience. 175:66–74. 2011.PubMed/NCBI View Article : Google Scholar

Reeta KH, Singh D and Gupta YK: Chronic treatment with taurine after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress, cholinergic functions and neuroinflammation. Neurochem Int. 108:146–156. 2017.PubMed/NCBI View Article : Google Scholar

Bharate SS, Kumar V, Singh G, Singh A, Gupta M, Singh D, Kumar A, Vishwakarma RA and Bharate SB: Preclinical development of Crocus sativus-based botanical lead IIIM-141 for Alzheimer's disease: Chemical standardization, efficacy, formulation development, pharmacokinetics, and safety pharmacology. ACS Omega. 3:9572–9585. 2018.PubMed/NCBI View Article : Google Scholar

Kapucu A: Crocin ameliorates oxidative stress and suppresses renal damage in streptozotocin induced diabetic male rats. Biotech Histochem. 96:153–160. 2021.PubMed/NCBI View Article : Google Scholar

Naghizadeh B, Mansouri MT, Ghorbanzadeh B, Farbood Y and Sarkaki A: Protective effects of oral crocin against intracerebroventricular streptozotocin-induced spatial memory deficit and oxidative stress in rats. Phytomedicine. 20:537–542. 2013.PubMed/NCBI View Article : Google Scholar

Asadi F, Jamshidi AH, Khodagholi F, Yans A, Azimi L, Faizi M, Vali L, Abdollahi M and Ghahremani MH: Reversal effects of crocin on amyloid β-induced memory deficit: Modification of autophagy or apoptosis markers. Pharmacol Biochem Behav. 139:47–58. 2015.PubMed/NCBI View Article : Google Scholar

Wang C, Cai X, Hu W, Li Z, Kong F, Chen X and Wang D: Investigation of the neuroprotective effects of crocin via antioxidant activities in HT22 cells and in mice with Alzheimer's disease. Int J Mol Med. 43:956–966. 2019.PubMed/NCBI View Article : Google Scholar

Osaki LH and Gama P: MAPKs and signal transduction in the control of gastrointestinal epithelial cell proliferation and differentiation. Int J Mol Sci. 14:10143–10161. 2013.PubMed/NCBI View Article : Google Scholar

Kim EK and Choi EJ: Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta. 1802:396–405. 2010.PubMed/NCBI View Article : Google Scholar

Shehzad A and Lee YS: Molecular mechanisms of curcumin action: Signal transduction. Biofactors. 39:27–36. 2013.PubMed/NCBI View Article : Google Scholar

Vriz S, Reiter S and Galliot B: Cell death: A program to regenerate. Curr Top Dev Biol. 108:121–151. 2014.PubMed/NCBI View Article : Google Scholar

Rafieipour F, Hadipour E, Emami SA, Asili J and Tayarani-Najaran Z: Safranal protects against beta-amyloid peptide-induced cell toxicity in PC12 cells via MAPK and PI3K pathways. Metab Brain Dis. 34:165–172. 2019.PubMed/NCBI View Article : Google Scholar

Baluchnejadmojarad T, Mohamadi-Zarch SM and Roghani M: Safranal, an active ingredient of saffron, attenuates cognitive deficits in amyloid β-induced rat model of Alzheimer's disease: Underlying mechanisms. Metab Brain Dis. 34:1747–1759. 2019.PubMed/NCBI View Article : Google Scholar

Alonso AC, Zaidi T, Grundke-Iqbal I and Iqbal K: Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci USA. 91:5562–5566. 1994.PubMed/NCBI View Article : Google Scholar

Chalatsa I, Arvanitis DA, Koulakiotis NS, Giagini A, Skaltsounis AL, Papadopoulou-Daifoti Z, Tsarbopoulos A and Sanoudou D: The Crocus sativus compounds trans-crocin 4 and trans-crocetin modulate the amyloidogenic pathway and tau misprocessing in Alzheimer disease neuronal cell culture models. Front Neurosci. 13(249)2019.PubMed/NCBI View Article : Google Scholar

Rashedinia M, Lari P, Abnous K and Hosseinzadeh H: Protective effect of crocin on acrolein-induced tau phosphorylation in the rat brain. Acta Neurobiol Exp (Wars). 75:208–219. 2015.PubMed/NCBI

Koulakiotis NS, Purhonen P, Gikas E, Hebert H and Tsarbopoulos A: Crocus-derived compounds alter the aggregation pathway of Alzheimer's disease: Associated beta amyloid protein. Sci Rep. 10(18150)2020.PubMed/NCBI View Article : Google Scholar

Haeri P, Mohammadipour A, Heidari Z and Ebrahimzadeh-Bideskan A: Neuroprotective effect of crocin on substantia nigra in MPTP-induced Parkinson's disease model of mice. Anat Sci Int. 94:119–127. 2019.PubMed/NCBI View Article : Google Scholar

Rao SV, Muralidhara Yenisetti SC and Rajini PS: Evidence of neuroprotective effects of saffron and crocin in a Drosophila model of parkinsonism. Neurotoxicology. 52:230–242. 2016.PubMed/NCBI View Article : Google Scholar

Finley JW and Gao S: A Perspective on Crocus sativus L. (saffron) constituent crocin: A potent water-soluble antioxidant and potential therapy for Alzheimer's disease. J Agric Food Chem. 65:1005–1020. 2017.PubMed/NCBI View Article : Google Scholar

Chen WW, Zhang X and Huang WJ: Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep. 13:3391–3396. 2016.PubMed/NCBI View Article : Google Scholar

Spencer JP, Vafeiadou K, Williams RJ and Vauzour D: Neuroinflammation: Modulation by flavonoids and mechanisms of action. Mol Aspects Med. 33:83–97. 2012.PubMed/NCBI View Article : Google Scholar

McManus RM and Heneka MT: Role of neuroinflammation in neurodegeneration: New insights. Alzheimers Res Ther. 9(14)2017.PubMed/NCBI View Article : Google Scholar

Simpson DSA and Oliver PL: ROS Generation in microglia: Understanding oxidative stress and inflammation in neurodegenerative disease. Antioxidants (Basel). 9(743)2020.PubMed/NCBI View Article : Google Scholar

Spagnuolo C, Moccia S and Russo GL: Anti-inflammatory effects of flavonoids in neurodegenerative disorders. Eur J Med Chem. 153:105–115. 2018.PubMed/NCBI View Article : Google Scholar

Korani S, Korani M, Sathyapalan T and Sahebkar A: Therapeutic effects of crocin in autoimmune diseases: A review. Biofactors. 45:835–843. 2019.PubMed/NCBI View Article : Google Scholar

Zhang J, Wang Y, Dong X and Liu J: Crocetin attenuates inflammation and amyloid-β accumulation in APPsw transgenic mice. Immun Ageing. 15(24)2018.PubMed/NCBI View Article : Google Scholar

Jurcau A and Simion A: Neuroinflammation in cerebral ischemia and ischemia/reperfusion injuries: From pathophysiology to therapeutic strategies. Int J Mol Sci. 23(14)2021.PubMed/NCBI View Article : Google Scholar

Das J and G K R: Post stroke depression: The sequelae of cerebral stroke. Neurosci Biobehav Rev. 90:104–114. 2018.PubMed/NCBI View Article : Google Scholar

Wang SH, Zhang ZJ, Guo YJ, Sui YX and Sun Y: Involvement of serotonin neurotransmission in hippocampal neurogenesis and behavioral responses in a rat model of post-stroke depression. Pharmacol Biochem Behav. 95:129–137. 2010.PubMed/NCBI View Article : Google Scholar

Xu QQ, Qian XD, Sun F, Liu H, Dou ZJ, Gong J and Zhang XR: Effects of crocin on inflammatory response and TLR4/MyD88/NF-κB signaling pathway in post-stroke depression rats. Chin J Immunol. 37:179–185. 2021.

Johannsen DL and Ravussin E: The role of mitochondria in health and disease. Curr Opin Pharmacol. 9:780–786. 2009.PubMed/NCBI View Article : Google Scholar

Hernández-Reséndiz S, Buelna-Chontal M, Correa F and Zazueta C: Targeting mitochondria for cardiac protection. Curr Drug Targets. 14:586–600. 2013.PubMed/NCBI View Article : Google Scholar

Lin MT and Beal MF: Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 443:787–795. 2006.PubMed/NCBI View Article : Google Scholar

Shults CW: Mitochondrial dysfunction and possible treatments in Parkinson's disease-a review. Mitochondrion. 4:641–648. 2004.PubMed/NCBI View Article : Google Scholar

Zhang GF, Zhang Y and Zhao G: Crocin protects PC12 cells against MPP(+)-induced injury through inhibition of mitochondrial dysfunction and ER stress. Neurochem Int. 89:101–110. 2015.PubMed/NCBI View Article : Google Scholar

Vongsfak J, Pratchayasakul W, Apaijai N, Vaniyapong T, Chattipakorn N and Chattipakorn SC: The alterations in mitochondrial dynamics following cerebral ischemia/reperfusion injury. Antioxidants (Basel). 10(1384)2021.PubMed/NCBI View Article : Google Scholar

Wen B: Study on the protective effect of crocin pretreatment on hippocampal mitochondria in the rats with ischemic brain injury. Mod J Integr Tradit Chin West Med. 29(6)2020.

Zhang YH, Cong WH and Liu JX: Effect of crocin on mitochondrial dynamics in SH-SY5Y cells against injury induced by oxygen-glucose deprivation. Chin Pharmacol Bull. 32:986–990. 2016.

Zhang YH, Yao MJ, Cong WH and Liu JX: Effect of extraction of saffron crocus on mitochondrial dynamics in ischemia/reperfusion rats. Chin Pharmacol Bull. 34:770–775. 2018.

Reddy PH: Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease. Brain Res. 1415:136–148. 2011.PubMed/NCBI View Article : Google Scholar

Lin L, Liu G and Yang L: Crocin improves cognitive behavior in rats with Alzheimer's disease by regulating endoplasmic reticulum stress and apoptosis. Biomed Res Int. 2019(9454913)2019.PubMed/NCBI View Article : Google Scholar

Hadipour M, Kaka G, Bahrami F, Meftahi GH, Pirzad Jahromi G, Mohammadi A and Sahraei H: Crocin improved amyloid beta induced long-term potentiation and memory deficits in the hippocampal CA1 neurons in freely moving rats. Synapse. 72(e22026)2018.PubMed/NCBI View Article : Google Scholar

Naghibi SM, Hosseini M, Khani F, Rahimi M, Vafaee F, Rakhshandeh H and Aghaie A: Effect of aqueous extract of Crocus sativus L. on morphine-induced memory impairment. Adv Pharmacol Sci. 2012(494367)2012.PubMed/NCBI View Article : Google Scholar

Mazumder AG, Sharma P, Patial V and Singh D: Crocin attenuates kindling development and associated cognitive impairments in mice via inhibiting reactive oxygen species-mediated NF-κB activation. Basic Clin Pharmacol Toxicol. 120:426–433. 2017.PubMed/NCBI View Article : Google Scholar

Canal CE, Chang Q and Gold PE: Amnesia produced by altered release of neurotransmitters after intraamygdala injections of a protein synthesis inhibitor. Proc Natl Acad Sci USA. 104:12500–12505. 2007.PubMed/NCBI View Article : Google Scholar

D'Amato RJ, Zweig RM, Whitehouse PJ, Wenk GL, Singer HS, Mayeux R, Price DL and Snyder SH: Aminergic systems in Alzheimer's disease and Parkinson's disease. Ann Neurol. 22:229–236. 1987.PubMed/NCBI View Article : Google Scholar

Müller ML and Bohnen NI: Cholinergic dysfunction in Parkinson's disease. Curr Neurol Neurosci Rep. 13(377)2013.PubMed/NCBI View Article : Google Scholar

Hall H, Reyes S, Landeck N, Bye C, Leanza G, Double K, Thompson L, Halliday G and Kirik D: Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease. Brain. 137:2493–2508. 2014.PubMed/NCBI View Article : Google Scholar

Geromichalos GD, Lamari FN, Papandreou MA, Trafalis DT, Margarity M, Papageorgiou A and Sinakos Z: Saffron as a source of novel acetylcholinesterase inhibitors: Molecular docking and in vitro enzymatic studies. J Agric Food Chem. 60:6131–6138. 2012.PubMed/NCBI View Article : Google Scholar

Pitsikas N and Sakellaridis N: Crocus sativus L. extracts antagonize memory impairments in different behavioural tasks in the rat. Behav Brain Res. 173:112–115. 2006.PubMed/NCBI View Article : Google Scholar

Pitsikas N, Zisopoulou S, Tarantilis PA, Kanakis CD, Polissiou MG and Sakellaridis N: Effects of the active constituents of Crocus sativus L., crocins on recognition and spatial rats' memory. Behav Brain Res. 183:141–146. 2007.PubMed/NCBI View Article : Google Scholar

White LD, Cory-Slechta DA, Gilbert ME, Tiffany-Castiglioni E, Zawia NH, Virgolini M, Rossi-George A, Lasley SM, Qian YC and Basha MR: New and evolving concepts in the neurotoxicology of lead. Toxicol Appl Pharmacol. 225:1–27. 2007.PubMed/NCBI View Article : Google Scholar

Bakulski KM, Seo YA, Hickman RC, Brandt D, Vadari HS, Hu H and Park SK: Heavy metals exposure and Alzheimer's disease and related dementias. J Alzheimers Dis. 76:1215–1242. 2020.PubMed/NCBI View Article : Google Scholar

Butnariu M, Quispe C, Herrera-Bravo J, Sharifi-Rad J, Singh L, Aborehab NM, Bouyahya A, Venditti A, Sen S, Acharya K, et al: The pharmacological activities of Crocus sativus L.: A review based on the mechanisms and therapeutic opportunities of its phytoconstituents. Oxid Med Cell Longev. 2022(8214821)2022.PubMed/NCBI View Article : Google Scholar

Tamegart L, Abbaoui A, Makbal R, Zroudi M, Bouizgarne B, Bouyatas MM and Gamrani H: Crocus sativus restores dopaminergic and noradrenergic damages induced by lead in Meriones shawi: A possible link with Parkinson's disease. Acta Histochem. 121:171–181. 2019.PubMed/NCBI View Article : Google Scholar

Sartori E and Edan G: Assessment of cognitive dysfunction in multiple sclerosis. J Neurol Sci. 245:169–175. 2006.PubMed/NCBI View Article : Google Scholar

Glanz BI, Healy BC, Hviid LE, Chitnis T and Weiner HL: Cognitive deterioration in patients with early multiple sclerosis: A 5-year study. J Neurol Neurosurg Psychiatry. 83:38–43. 2012.PubMed/NCBI View Article : Google Scholar

Ziehn MO, Avedisian AA, Tiwari-Woodruff S and Voskuhl RR: Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE. Lab Invest. 90:774–786. 2010.PubMed/NCBI View Article : Google Scholar

Ghaffari S, Hatami H and Dehghan G: Saffron ethanolic extract attenuates oxidative stress, spatial learning, and memory impairments induced by local injection of ethidium bromide. Res Pharm Sci. 10:222–232. 2015.PubMed/NCBI

Bonuccelli U, Meco G, Fabbrini G, Tessitore A, Pierantozzi M, Stocchi F, Ceravolo R, Caltagirone C, Silvestrini M, Morgante F, et al: A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease. Expert Opin Pharmacother. 13:2269–2280. 2012.PubMed/NCBI View Article : Google Scholar

Dobkin RD, Menza M, Bienfait KL, Gara M, Marin H, Mark MH, Dicke A and Friedman J: Depression in Parkinson's disease: Symptom improvement and residual symptoms after acute pharmacologic management. Am J Geriatr Psychiatry. 19:222–229. 2011.PubMed/NCBI View Article : Google Scholar

Lozupone M, La Montagna M, D'Urso F, Piccininni C, Sardone R, Dibello V, Giannelli G, Solfrizzi V, Greco A, Daniele A, et al: Pharmacotherapy for the treatment of depression in patients with alzheimer's disease: A treatment-resistant depressive disorder. Expert Opin Pharmacother. 19:823–842. 2018.PubMed/NCBI View Article : Google Scholar

Novais F and Starkstein S: Phenomenology of depression in Alzheimer's disease. J Alzheimers Dis. 47:845–855. 2015.PubMed/NCBI View Article : Google Scholar

Pålhagen S, Qi H, Mårtensson B, Wålinder J, Granérus AK and Svenningsson P: Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression. J Neurol. 257:524–532. 2010.PubMed/NCBI View Article : Google Scholar

Schrag A and Taddei RN: Depression and anxiety in Parkinson's disease. Int Rev Neurobiol. 133:623–655. 2017.PubMed/NCBI View Article : Google Scholar

Xiao Q, Xiong Z, Yu C, Zhou J, Shen Q, Wang L, Xie X and Fu Z: Antidepressant activity of crocin-I is associated with amelioration of neuroinflammation and attenuates oxidative damage induced by corticosterone in mice. Physiol Behav. 212(112699)2019.PubMed/NCBI View Article : Google Scholar

Ghadrdoost B, Vafaei AA, Rashidy-Pour A, Hajisoltani R, Bandegi AR, Motamedi F, Haghighi S, Sameni HR and Pahlvan S: Protective effects of saffron extract and its active constituent crocin against oxidative stress and spatial learning and memory deficits induced by chronic stress in rats. Eur J Pharmacol. 667:222–229. 2011.PubMed/NCBI View Article : Google Scholar

Halataei BAS, Khosravi M, Arbabian S, Sahraei H, Golmanesh L, Zardooz H, Jalili C and Ghoshooni H: Saffron (Crocus sativus) aqueous extract and its constituent crocin reduces stress-induced anorexia in mice. Phytother Res. 25:1833–1838. 2011.PubMed/NCBI View Article : Google Scholar

Ghasemi T, Abnous K, Vahdati F, Mehri S, Razavi BM and Hosseinzadeh H: Antidepressant effect of Crocus sativus aqueous extract and its effect on CREB, BDNF, and VGF transcript and protein levels in rat hippocampus. Drug Res (Stuttg). 65:337–343. 2015.PubMed/NCBI View Article : Google Scholar

Vahdati Hassani F, Naseri V, Razavi BM, Mehri S, Abnous K and Hosseinzadeh H: Antidepressant effects of crocin and its effects on transcript and protein levels of CREB, BDNF, and VGF in rat hippocampus. Daru. 22(16)2014.PubMed/NCBI View Article : Google Scholar

Cano A, Fonseca E, Ettcheto M, Sánchez-López E, de Rojas I, Alonso-Lana S, Morató X, Souto EB, Toledo M, Boada M, et al: Epilepsy in neurodegenerative diseases: Related drugs and molecular pathways. Pharmaceuticals (Basel). 14(1057)2021.PubMed/NCBI View Article : Google Scholar

Vezzani A, French J, Bartfai T and Baram TZ: The role of inflammation in epilepsy. Nat Rev Neurol. 7:31–40. 2011.PubMed/NCBI View Article : Google Scholar

Filippini A, D'Amore A and D'Alessio A: Calcium mobilization in endothelial cell functions. Int J Mol Sci. 20(4525)2019.PubMed/NCBI View Article : Google Scholar

Maklad A, Sharma A and Azimi I: Calcium signaling in brain cancers: Roles and therapeutic targeting. Cancers (Basel). 11(145)2019.PubMed/NCBI View Article : Google Scholar

Schrank S, Barrington N and Stutzmann GE: Calcium-handling defects and neurodegenerative disease. Cold Spring Harb Perspect Biol. 12(a035212)2020.PubMed/NCBI View Article : Google Scholar

Xing B, Li S, Yang J, Lin D, Feng Y, Lu J and Shao Q: Phytochemistry, pharmacology, and potential clinical applications of saffron: A review. J Ethnopharmacol. 281(114555)2021.PubMed/NCBI View Article : Google Scholar

Zhao Z, Zheng B, Li J, Wei Z, Chu S, Han X, Chu L, Wang H and Chu X: Influence of crocetin, a natural carotenoid dicarboxylic acid in saffron, on L-type Ca²⁺ current, intracellular Ca²⁺ handling and contraction of isolated rat cardiomyocytes. Biol Pharm Bull. 43:1367–1374. 2020.PubMed/NCBI View Article : Google Scholar

Moshiri M, Vahabzadeh M and Hosseinzadeh H: Clinical Applications of saffron (Crocus sativus) and its constituents: A review. Drug Res (Stuttg). 65:287–295. 2015.PubMed/NCBI View Article : Google Scholar

Omidkhoda SF and Hosseinzadeh H: Saffron and its active ingredients against human disorders: A literature review on existing clinical evidence. Iran J Basic Med Sci. 25:913–933. 2022.PubMed/NCBI View Article : Google Scholar

Foster ER: Themes from the special issue on neurodegenerative diseases: What have we learned, and where can we go from here? Am J Occup Ther. 68:6–8. 2014.PubMed/NCBI View Article : Google Scholar

Akhondzadeh S, Shafiee Sabet M, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi SS, Yousefi MH, Alimardani R, Jamshidi A, et al: A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease. Psychopharmacology (Berl). 207:637–643. 2010.PubMed/NCBI View Article : Google Scholar

Asadollahi M, Nikdokht P, Hatef B, Sadr SS, Sahraei H, Assarzadegan F and Pirzad Jahromi G: Protective properties of the aqueous extract of saffron (Crocus sativus L.) in ischemic stroke, randomized clinical trial. J Ethnopharmacol. 238(111833)2019.PubMed/NCBI View Article : Google Scholar

Zandi N, Pazoki B, Momeni Roudsari N, Lashgari NA, Jamshidi V, Momtaz S, Abdolghaffari AH and Akhondzadeh S: Prospects of saffron and its derivatives in Alzheimer's disease. Arch Iran Med. 24:233–252. 2021.PubMed/NCBI View Article : Google Scholar

Marzabadi LR, Fazljou SMB, Araj-Khodaei M, Sadigh-Eteghad S, Naseri A and Talebi M: Saffron reduces some inflammation and oxidative stress markers in donepezil-treated mild-to-moderate Alzheimer's disease patients: A randomized double-blind placebo-control trial. J Herb Med. 34(100574)2022.